Great Novel Therapeutics Biotech & Medicals (ROCO:7427) FCF Margin % : -37,839.77% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Great Novel Therapeutics Biotech & Medicals's Free Cash Flow for the six months ended in Dec. 2023 was NT$-33.30 Mil. Great Novel Therapeutics Biotech & Medicals's Revenue for the six months ended in Dec. 2023 was NT$0.09 Mil. Therefore, Great Novel Therapeutics Biotech & Medicals's FCF Margin % for the quarter that ended in Dec. 2023 was -37,839.77%.

As of today, Great Novel Therapeutics Biotech & Medicals's current FCF Yield % is -3.74%.

The historical rank and industry rank for Great Novel Therapeutics Biotech & Medicals's FCF Margin % or its related term are showing as below:

ROCO:7427' s FCF Margin % Range Over the Past 10 Years
Min: -58422.73 Med: -9828.73 Max: -1178.12
Current: -1530.06

During the past 6 years, the highest FCF Margin % of Great Novel Therapeutics Biotech & Medicals was -1178.12%. The lowest was -58422.73%. And the median was -9828.73%.

ROCO:7427's FCF Margin % is ranked worse than
79.98% of 1039 companies
in the Biotechnology industry
Industry Median: -139.09 vs ROCO:7427: -1530.06

Great Novel Therapeutics Biotech & Medicals FCF Margin % Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals FCF Margin % Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-58,422.73

-9,828.73

-14,516.30

-1,530.06

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-10,444.24	-5,353.33	-	-859.07	-37,839.77

Competitive Comparison of Great Novel Therapeutics Biotech & Medicals's FCF Margin %

For the Biotechnology subindustry, Great Novel Therapeutics Biotech & Medicals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Novel Therapeutics Biotech & Medicals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Great Novel Therapeutics Biotech & Medicals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Great Novel Therapeutics Biotech & Medicals's FCF Margin % falls into.

Great Novel Therapeutics Biotech & Medicals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Great Novel Therapeutics Biotech & Medicals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-74.208	/	4.85
	=	-1,530.06 %

Great Novel Therapeutics Biotech & Medicals's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-33.299	/	0.088
	=	-37,839.77 %

Great Novel Therapeutics Biotech & Medicals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines